<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Norethindrone</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00717</strong>&#160; (APRD00679)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A synthetic progestational hormone with actions similar to those of progesterone but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00717/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00717/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00717.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00717.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00717.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00717.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00717.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00717">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>17&#945;-ethinyl-19-nortestosterone</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>19-nor-17&#945;-ethynyltestosterone</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>19-Norethisterone</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Norethisterone</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>INN</td></tr><tr><td>Norethisteronum</td><td>Latin</td><td>INN</td></tr><tr><td>Noretisterona</td><td>Spanish</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Norethindrone Acetate </strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000129/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000129/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: IMONTRJLAWHYGT-ZCPXKWAGSA-N</li>
              <li>Monoisotopic Mass: 340.203844762</li>
              <li>Average Mass: 340.4559</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000129">DBSALT000129</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Aygestin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Camila</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Errin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>HEATHER</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Jencycla</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Jolivette</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>LYZA</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Micronor</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>NORLYROC</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Primolut-N</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Brevicon 0.5/35 (21 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Brevicon 0.5/35 (28 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Brevicon 0.5/35 Tablets (21 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Brevicon 0.5/35 Tablets (28 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Brevicon 1/35 Tablets (21 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Brevicon 1/35 Tablets (28 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>CombiPatch</td><td>Norethindrone + Estradiol</td></tr><tr><td>Estalis 140/50 Mcg</td><td>Estradiol + Norethindrone Acetate</td></tr><tr><td>Estalis 250/50 Mcg</td><td>Estradiol + Norethindrone Acetate</td></tr><tr><td>Estalis Sequi</td><td>Estradiol + Norethindrone Acetate</td></tr><tr><td>Estracomb</td><td>Estradiol + Norethindrone Acetate</td></tr><tr><td>femhrt</td><td>Norethindrone + Ethinyl Estradiol</td></tr><tr><td>Femhrt 1/5</td><td>Ethinyl Estradiol + Norethindrone Acetate</td></tr><tr><td>Jinteli</td><td>Norethindrone + Ethinyl Estradiol</td></tr><tr><td>JINTELI</td><td>Norethindrone + Ethinyl Estradiol</td></tr><tr><td>Lo Minastrin </td><td>Norethindrone acetate, ethinyl estradiol, ferrous fumarate</td></tr><tr><td>Loestrin 1.5/30 21-day Pack</td><td>Ethinyl Estradiol + Norethindrone Acetate</td></tr><tr><td>Loestrin 1.5/30 28-day Pack</td><td>Ethinyl Estradiol + Norethindrone Acetate</td></tr><tr><td>Mimvey</td><td>Norethindrone + Estradiol</td></tr><tr><td>Minestrin 1/20 21</td><td>Ethinyl Estradiol + Norethindrone Acetate</td></tr><tr><td>Minestrin 1/20 28</td><td>Ethinyl Estradiol + Norethindrone Acetate</td></tr><tr><td>Norinyl 1/50 - 21-day pack</td><td>Mestranol + Norethindrone</td></tr><tr><td>Norinyl 1/50 - 28-day pack</td><td>Mestranol + Norethindrone</td></tr><tr><td>Norinyl 1/50 (21 day)</td><td>Mestranol + Norethindrone</td></tr><tr><td>Norinyl 1/50 (28 day)</td><td>Mestranol + Norethindrone</td></tr><tr><td>Ortho 0.5/35 Tablets (21 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ortho 0.5/35 Tablets (28 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ortho 1/35 Tablets (21 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ortho 1/35 Tablets (28 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ortho 10/11 Tablets (21 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ortho 10/11 Tablets (28 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ortho 7/7/7 Tablets (21 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ortho 7/7/7 Tablets (28 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Ortho-Novum 1/50 Tablets (21 day)</td><td>Mestranol + Norethindrone</td></tr><tr><td>Ortho-Novum 1/50 Tablets (28 day)</td><td>Mestranol + Norethindrone</td></tr><tr><td>Select 1/35 (21 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Select 1/35 (28 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Synphasic (21 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr><tr><td>Synphasic (28 day)</td><td>Ethinyl Estradiol + Norethindrone</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/contraceptives-oral-synthetic">Contraceptives, Oral, Synthetic</a></li></ul></td></tr><tr><th>CAS number</th><td>68-22-4</td></tr><tr><th>Weight</th><td>Average: 298.4192<br>Monoisotopic: 298.193280076</td></tr><tr><th>Chemical Formula</th><td>C<sub>20</sub>H<sub>26</sub>O<sub>2</sub></td></tr><tr><th>InChI Key</th><td>VIKNJXKGJWUCNN-XGXHKTLJSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22H,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(1S,2R,10R,11S,14R,15S)-14-ethynyl-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one</div></td></tr><tr><th>SMILES</th><td><div class="wrap">[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00717.gif?1265922772">show</a>(11.3 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Lipids</td></tr><tr><th>Class</th><td>Steroids and Steroid Derivatives</td></tr><tr><th>Subclass</th><td>Ketosteroids</td></tr><tr><th>Direct parent</th><td>Ketosteroids</td></tr><tr><th>Alternative parents</th><td>Hydroxysteroids; Estrogens and Derivatives; Ynones; Tertiary Alcohols; Cyclic Alcohols and Derivatives; Polyamines</td></tr><tr><th>Substituents</th><td>ynone; tertiary alcohol; cyclic alcohol; ketone; polyamine; alcohol; carbonyl group</td></tr><tr><th>Classification description</th><td>This compound belongs to the ketosteroids. These are steroid derivatives comprising a ketone group attached to steroid skeleton.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>Norethindrone acetate is indicated for the treatment of secondary amenorrhea, endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer.</td></tr><tr><th>Pharmacodynamics</th><td>Norethindrone is a synthetic oral progestin. It is used for contraception or to treat such conditions as secondary amenorrhea, abnormal uterine bleeding, and endometriosis. As an oral contraceptive, norethindrone is available as either a single agent or in combination with an estrogen. Norethindrone acetate induces secretory changes in an estrogen-primed endometrium. On a weight basis, it is twice as potent as norethindrone.</td></tr><tr><th>Mechanism of action</th><td>Progestins diffuse freely into target cells and bind to the progesterone receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH surge.</td></tr><tr><th>Absorption</th><td>Norethindrone acetate is completely and rapidly deacetylated to norethindrone (NET) after oral administration, and the disposition of norethindrone acetate is indistinguishable from that of orally administered norethindrone. Norethindrone is rapidly absorbed from norethindrone acetate, in which maximum plasma concentration occur 2 hours post-dose (Tmax). When a single dose is given to healthy women, the Cmax is 26.19 &#177; 6.19 hours. The AUC (0-inf) is 166.90 &#177; 56.28 ng/mL*h. Absolute oral bioavailability is approximately 64%. The effect of food on the pharmacokinetics of norethindrone acetate is unknown. </td></tr><tr><th>Volume of distribution</th><td><ul>
	<li>4 L/kg</li>
</ul></td></tr><tr><th>Protein binding</th><td>Norethindrone is 36% bound to sex hormone-binding globulin and 61% bound to albumin. </td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic. Norethindrone is extensively metabolized, primarily via reduction. It also undergoes sulfate and glucuronide conjugation. The majority of metabolites in the circulation are sulfates, with glucuronides accounting for most of the urinary metabolites.</p></td></tr><tr><th>Route of elimination</th><td>Norethindrone is excreted in both urine and feces, primarily as metabolites.</td></tr><tr><th>Half life</th><td>8.51 &#177; 2.19 (when a single dose is given to healthy women) </td></tr><tr><th>Clearance</th><td><ul>
	<li>0.4 L/hr/kg [plasma clearance]</li>
</ul></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>1.0</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9413</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.8572</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.6346</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Inhibitor
        </td>
        <td>0.5079</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9087</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.7603</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7759</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9237</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.7415</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.844</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8688</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9386</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Inhibitor</td>
        <td>0.8994</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8333</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.7876</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9319
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9417
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9512
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          1.8788 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8777
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7744
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Parke davis div warner lambert co</li>
<li>Barr laboratories inc</li>
<li>Glenmark generics ltd</li>
<li>Ortho mcneil janssen pharmaceuticals inc</li>
<li>Watson laboratories inc</li>
<li>Duramed research inc</li>
<li>Glenmark generics ltd india</li>
<li>Warner Chilcott</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li>Barr Pharmaceuticals</li>
<li><a href="http://www.bpirx.com">Breckenridge Pharmaceuticals</a></li>
<li><a href="http://www.bms.com">Bristol-Myers Squibb Co.</a></li>
<li>Dept Health Central Pharmacy</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li><a href="http://www.duramed.ca">Duramed</a></li>
<li><a href="http://www.glenmark-generics.com">Glenmark Generics Ltd.</a></li>
<li>Innovative Manufacturing and Distribution Services Inc.</li>
<li>Kaiser Foundation Hospital</li>
<li>Lake Erie Medical and Surgical Supply</li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li><a href="http://www.novartis.com">Novartis AG</a></li>
<li><a href="http://www.noven.com">Noven Pharmaceuticals Inc.</a></li>
<li><a href="http://www.novonordisk.com">Novo Nordisk Inc.</a></li>
<li><a href="http://www.ortho-mcneil.com">Ortho Mcneil Janssen Pharmaceutical Inc.</a></li>
<li><a href="http://www.ortho-mcneil.com">Ortho-McNeil-Janssen Pharmaceuticals Inc.</a></li>
<li><a href="http://www.patheon.com">Patheon Inc.</a></li>
<li><a href="http://www.pfizer.com">Pfizer Inc.</a></li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li><a href="http://www.pharm-int.com">Pharmaceutics International Inc.</a></li>
<li><a href="http://www.pharmaciaupjohn.com">Pharmacia Inc.</a></li>
<li><a href="http://www.pplpho.org">Physician Partners Ltd.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.worldoftest.com">Qualitest</a></li>
<li>Quality Care</li>
<li>Redpharm Drug</li>
<li><a href="http://www.southwoodhealthcare.com">Southwood Pharmaceuticals</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://ir.wcrx.com">Warner Chilcott Co. Inc.</a></li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li>
<li>WC Pharmaceuticals</li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Tablet</td><td>Oral</td><td>0.35 mg, 5 mg</td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00459">Acitretin</a></td><td>Acitretine may cause a loss of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01351">Amobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01352">Aprobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB06697">Artemether</a></td><td>Artemether may decrease the effectiveness of norethindrone by increasing its metabolism via CYP3A4. Consider an alternate non-hormonal means of contraception during artemether therapy.</td></tr><tr><td><a href="/drugs/DB00307">Bexarotene</a></td><td>Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of norethindrone, it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form).</td></tr><tr><td><a href="/drugs/DB00559">Bosentan</a></td><td>Bosentan may decrease the contraceptive effect of norethindrone. Hormonal contraception should not be relied on alone during concomitant therapy with bosentan.</td></tr><tr><td><a href="/drugs/DB00237">Butabarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00241">Butalbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01353">Butethal</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00930">Colesevelam</a></td><td>Bile Acid Sequestrants may decrease the serum concentration of Contraceptives (Progestins). Administer oral progestin-containing contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant. Consider alternatives in order to avoid this combination when possible, due to the risk for impaired contraceptive effectiveness. </td></tr><tr><td><a href="/drugs/DB00754">Ethotoin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00400">Griseofulvin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01354">Heptabarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01355">Hexobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00555">Lamotrigine</a></td><td>The oral contraceptive decreases the effect of lamotrigine</td></tr><tr><td><a href="/drugs/DB00532">Mephenytoin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00474">Methohexital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00849">Methylphenobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00312">Pentobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01132">Pioglitazone</a></td><td>Possible loss of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00615">Rifabutin</a></td><td>Rifabutin may decrease the contraceptive effect of norethindrone. Hormonal contraception should not be solely relied on alone during concomitant therapy with rifabutin.</td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01201">Rifapentine</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB06201">Rufinamide</a></td><td>Rufinamide decreases plasma concentrations of norethindrone, thus consider therapy modification </td></tr><tr><td><a href="/drugs/DB00418">Secobarbital</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB01323">St. John's Wort</a></td><td>St. John's Wort could reduce the contraceptive effect</td></tr><tr><td><a href="/drugs/DB00306">Talbutal</a></td><td>This product may cause a slight decrease of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00599">Thiopental</a></td><td>Thiopental may decrease the effect of Norethindrone. Contraceptive failure may occur. Alternative nonhomomonal contraception should be used during concomitant therapy. </td></tr><tr><td><a href="/drugs/DB00697">Tizanidine</a></td><td>The contraceptive increases the effect of tizanidine</td></tr><tr><td><a href="/drugs/DB00755">Tretinoin</a></td><td>Oral Tretinoin may decrease the effect of oral contraceptive, Norethindrone. An alternate form of contraception should be used during concomitant therapy. </td></tr><tr><td><a href="/drugs/DB00197">Troglitazone</a></td><td>Possible loss of contraceptive effect</td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>Norethindrone may alter the anticoagulant effect of warfarin. Concomitant therapy should be avoided. Monitor for changes in coagulation status if norethindrone is initiated, discontinued or dose changed.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Take without regard to meals.</li></ul></td></tr></tbody></table>